Research Scientist - (3279172)
General Summary/Overview Statement:
The Ragon Institute is a highly unique, innovative, and collaborative research center at the forefront of biomedical science. Founded by Massachusetts General Hospital, MIT, and Harvard, the Ragon vision is a bold one: to harness the power of the immune system to prevent and cure human disease on a global scale. This vision is pursued and advanced every day by a group of highly motivated individuals. The Ragon Institute, at every level, depends upon collaboration, compassion, dedication, and innovation. It is a results-oriented organization that seeks people who not only embrace these values but who thrive in teams and want to work in a dynamic environment.
A position is open for a full-time research scientist in the Balazs Lab at the Ragon Institute. The person hired will work in a group conducting basic and translational laboratory research on engineering immunity against infectious diseases.
The research in this area will focus on understanding the underlying mechanisms of immunogenicity following gene transfer by Adeno Associated Virus vectors. They will also conduct virological and immunological experiments, including but not limited to designing lentiviral and adeno associated viral vectors. Perform animal experiments with regular and humanized mice with the goal of understanding the interplay between pathogens and engineered host immune responses. The research scientist will work under the supervision of the PI and will be involved in collaborative studies within the Ragon Institute and with outside collaborators. He/she is also expected to contribute to the implementation of novel technologies at the Ragon Institute.
This is a great opportunity for someone with extensive experience in molecular virology research to diversify his/her research experience through studying immunology of an crucial translational technology. The position can serve as an ideal step before transition either to independent research in an academic setting, or a career in the pharmaceutical industry. In the perspective of this transition to a more senior position, the senior research scientist, will be encouraged to seek personal funding and will contribute to the writing of larger grants.
We are looking for a highly motivated candidate with extensive previous experience in molecular virology techniques. Experience with work in BL2/BL2+ conditions required. At least five years of postdoctoral research experience and a track record of research publications in virology are required. The Ragon Institute of MGH, MIT and Harvard offer an outstanding research environment with cutting-edge research facilities and multidisciplinary training opportunities.
Job Duties:
The above job description details the major duties and qualifications of the listed position. The individual hired to this position confirms that they are able to perform all duties outlined. Although the specific duties and responsibilities of this position may vary slightly, the supervisor of this position will ensure that the individual hired to this position is trained and qualified to complete each task assigned.
EEO Statement Massachusetts General Hospital is an Affirmative Action Employer. By embracing diverse skills, perspectives and ideas, we choose to lead. All qualified applicants will receive consideration for employment without regard to race, color, religious creed, national origin, sex, age, gender identity, disability, sexual orientation, military service, genetic information, and/or other status protected under law. We will ensure that all individuals with a disability are provided a reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment.
: MA-Cambridge-MGH 400 Technology
:
MGH 400 Technology
400 Technology Square
Cambridge 02139
: Technician/Technologist/Scientist
: Massachusetts General Hospital(MGH)
: Full-time
Standard Hours: 40
: Day Job
: Regular
Recruiting Department: Ragon Institute
: Feb 23, 2024
Read Full Description